BACKGROUND: In this study, we tested the efficacy of a low-intensity lifestyle intervention aimed at reducing the risk of cardiovascular disease among mid-life individuals. METHODS: We conducted a randomized controlled trial in which participants were randomly assigned either to receive a health report card with counselling (from a Telehealth nurse) on smoking, exercise, nutrition and stress or to receive usual care. The patients were divided into 2 groups on the basis of risk: the primary prevention group, with a Framingham risk score of 10% or higher (intervention, n = 157; control, n = 158), and the secondary prevention group, who had a diagnosis of coronary artery disease (intervention, n = 153; control, n = 143). The primary outcome was a change in the Framingham global risk score between baseline and 1-year follow-up. Data were analyzed separately for the 2 prevention groups using an intention-to-treat analysis controlling for covariates. RESULTS: Within the primary prevention group, there were statistically significant changes for the treatment group relative to the controls, from baseline to year 1, in Framingham score (intervention, -3.10 [95% confidence interval (CI) -3.98 to -2.22]; control, -1.30 [95% CI -2.18 to -0.42]; p < 0.01) and scores for total cholesterol (intervention, -0.41 [95% CI -0.59 to -0.23]; control, -0.14 [95% CI -0.32 to 0.04]; p < 0.05), systolic blood pressure (intervention, -7.49 [95% CI -9.97 to -5.01]; control, -3.58 [95% CI -6.08 to -1.08]; p < 0.05), nutrition level (intervention, 0.30 [95% CI 0.13 to 0.47]; control, -0.05 [95% CI -0.22 to 0.12]; p < 0.01), and health confidence (intervention, 0.20 [95% CI 0.09 to 0.31]; control, 0.04 [95% CI -0.07 to 0.15]; p < 0.05), with adjustment for covariates. No significant changes in outcome variables were found for the secondary prevention group. INTERPRETATION: We found evidence for the efficacy of an intervention addressing multiple risk factors for primary prevention at 1 year using Framingham risk score report cards and telephone counselling. (Requirement for clinical trial registration waived [enrolment completed before requirement became applicable].).
RCT Entities:
BACKGROUND: In this study, we tested the efficacy of a low-intensity lifestyle intervention aimed at reducing the risk of cardiovascular disease among mid-life individuals. METHODS: We conducted a randomized controlled trial in which participants were randomly assigned either to receive a health report card with counselling (from a Telehealth nurse) on smoking, exercise, nutrition and stress or to receive usual care. The patients were divided into 2 groups on the basis of risk: the primary prevention group, with a Framingham risk score of 10% or higher (intervention, n = 157; control, n = 158), and the secondary prevention group, who had a diagnosis of coronary artery disease (intervention, n = 153; control, n = 143). The primary outcome was a change in the Framingham global risk score between baseline and 1-year follow-up. Data were analyzed separately for the 2 prevention groups using an intention-to-treat analysis controlling for covariates. RESULTS: Within the primary prevention group, there were statistically significant changes for the treatment group relative to the controls, from baseline to year 1, in Framingham score (intervention, -3.10 [95% confidence interval (CI) -3.98 to -2.22]; control, -1.30 [95% CI -2.18 to -0.42]; p < 0.01) and scores for total cholesterol (intervention, -0.41 [95% CI -0.59 to -0.23]; control, -0.14 [95% CI -0.32 to 0.04]; p < 0.05), systolic blood pressure (intervention, -7.49 [95% CI -9.97 to -5.01]; control, -3.58 [95% CI -6.08 to -1.08]; p < 0.05), nutrition level (intervention, 0.30 [95% CI 0.13 to 0.47]; control, -0.05 [95% CI -0.22 to 0.12]; p < 0.01), and health confidence (intervention, 0.20 [95% CI 0.09 to 0.31]; control, 0.04 [95% CI -0.07 to 0.15]; p < 0.05), with adjustment for covariates. No significant changes in outcome variables were found for the secondary prevention group. INTERPRETATION: We found evidence for the efficacy of an intervention addressing multiple risk factors for primary prevention at 1 year using Framingham risk score report cards and telephone counselling. (Requirement for clinical trial registration waived [enrolment completed before requirement became applicable].).
Authors: Neil F Gordon; Richard D Salmon; Barry A Franklin; Laurence S Sperling; Linda Hall; Richard F Leighton; William L Haskell Journal: Am J Cardiol Date: 2004-12-15 Impact factor: 2.778
Authors: Kim T B Knoops; Lisette C P G M de Groot; Daan Kromhout; Anne-Elisabeth Perrin; Olga Moreiras-Varela; Alessandro Menotti; Wija A van Staveren Journal: JAMA Date: 2004-09-22 Impact factor: 56.272
Authors: W L Haskell; E L Alderman; J M Fair; D J Maron; S F Mackey; H R Superko; P T Williams; I M Johnstone; M A Champagne; R M Krauss Journal: Circulation Date: 1994-03 Impact factor: 29.690
Authors: R F DeBusk; N H Miller; H R Superko; C A Dennis; R J Thomas; H T Lew; W E Berger; R S Heller; J Rompf; D Gee; H C Kraemer; A Bandura; G Ghandour; M Clark; R V Shah; L Fisher; C B Taylor Journal: Ann Intern Med Date: 1994-05-01 Impact factor: 25.391
Authors: R Jay Widmer; Nerissa M Collins; C Scott Collins; Colin P West; Lilach O Lerman; Amir Lerman Journal: Mayo Clin Proc Date: 2015-04 Impact factor: 7.616
Authors: Brodie M Sakakibara; Scott A Lear; Susan I Barr; Oscar Benavente; Charlie H Goldsmith; Noah D Silverberg; Jennifer Yao; Janice J Eng Journal: Arch Phys Med Rehabil Date: 2017-02-20 Impact factor: 3.966
Authors: Stephen D Persell; Donald M Lloyd-Jones; Elisha M Friesema; Andrew J Cooper; David W Baker Journal: J Gen Intern Med Date: 2012-11-11 Impact factor: 5.128
Authors: Davene R Wright; Paula Lozano; Elizabeth Dawson-Hahn; Dimitri A Christakis; Wren L Haaland; Anirban Basu Journal: Acad Pediatr Date: 2016-02-12 Impact factor: 3.107
Authors: David J Decewicz; David M Neatrour; Amy Burke; Mary Jane Haberkorn; Heather L Patney; Marina N Vernalis; Darrell L Ellsworth Journal: Lipids Health Dis Date: 2009-06-29 Impact factor: 3.876
Authors: Jun Ma; Kathy Berra; William L Haskell; Linda Klieman; Shauna Hyde; Mark W Smith; Lan Xiao; Randall S Stafford Journal: Arch Intern Med Date: 2009-11-23